![Nicholas Maragakis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicholas Maragakis
Corporate Officer/Principal bei Q Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Nicholas Maragakis
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicholas Maragakis
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
THERMOGENESIS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Capital Health Venture Partners
![]() Capital Health Venture Partners Investment ManagersFinance Capital Health Venture Partners is an alternative investment manager. The private company is based in Chicago, IL and has subsidiaries in the United States. The company was founded in 1985 by Daniel J. Mitchell. | Investment Managers | Corporate Officer/Principal | |
Q Therapeutic Products, Inc.
![]() Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Founder Director of Finance/CFO | |
EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
REBUS HOLDINGS, INC. | Biotechnology | Chairman | |
CereHealth Corp.
![]() CereHealth Corp. Medical/Nursing ServicesHealth Services CereHealth Corp. engages in the production of brain imaging software by utilizing high resolution gamma cameras. It specializes in Single-Photon Emission Computed Tomography (SPECT) & Positron Emission Tomography (PET). The company is headquartered in Littleton, CO. | Medical/Nursing Services | Director/Board Member | |
Pelion Venture Partners
![]() Pelion Venture Partners Investment ManagersFinance Pelion Venture Partners (Pelion Venture Partners) is a venture capital firm founded in 1986 by Jim C. Dreyfous and Joel D. Kellman. The firm is headquartered in Salt Lake City. Utah. | Investment Managers | Corporate Officer/Principal | |
Frontenac Co. LLC
![]() Frontenac Co. LLC Investment ManagersFinance Frontenac Co. LLC (Frontenac) is a private equity firm founded in 1971. The firm is headquartered in Chicago, Illinois. | Investment Managers | Corporate Officer/Principal | |
Covington & Burling LLP
![]() Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Covington & Burling LLP provides legal services. It also provides support services in the following administrative departments including accounting, human resources, information research services, information technology services, library, operations, marketing, practice systems support, recruitment, attorney and alumni relations, and professional development. The company was founded by J. Harry Covington and Edward B. Burling on January 1, 1919 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | General Counsel | |
University of Utah | College/University | Corporate Officer/Principal | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
Rutgers State University of New Jersey | College/University | Graduate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal | |
Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
California Institute of Technology
![]() California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree | |
The University of Arkansas | College/University | Doctorate Degree | |
University of California, Santa Barbara | College/University | Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
University of Mumbai | College/University | Undergraduate Degree | |
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Director/Board Member Director/Board Member | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | General Counsel Chairman | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Kearny Venture Partners
![]() Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
National Centre for Biological Sciences
![]() National Centre for Biological Sciences Miscellaneous Commercial ServicesCommercial Services The National Centre for Biological Sciences (NCBS) is a research institute located in Bangalore, IN. The Tata Institute for Genetics and Society (TIGS) is a non-profit research institute that aspires to develop solutions to challenges in human health and agriculture using applications of cutting-edge science and technology in genetics and genomics. The NCBS conducts research on various topics such as the assembly of mixed and branched heterotypic ubiquitin chains, evolution, and dopamine-neuropeptide axis maintenance in Drosophila. The institute has also been involved in tracking COVID and dengue through sewage surveillance. The institute is part of the Tata Institute of Fundamental Research and is dedicated to the study of stem cell and regenerative biology. The center for cellular and molecular platforms (C-CAMP) is an initiative of the Department of Biotechnology, Ministry of Science and Technology, with a mandate to be an enabler of cutting-edge life science research and innovation. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Institute on Aging | General Government | Corporate Officer/Principal | |
Upstart Ventures LLC
![]() Upstart Ventures LLC Investment ManagersFinance UpStart Ventures LLC (UpStart Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Salt Lake City, Utah. | Investment Managers | Private Equity Investor | |
Navigen, Inc.
![]() Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Founder Director/Board Member | |
Epiva Biosciences, Inc.
![]() Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Proterris, Inc.
![]() Proterris, Inc. Pharmaceuticals: MajorHealth Technology Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Placon Therapeutics, Inc.
![]() Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
XableCath, Inc.
![]() XableCath, Inc. Medical SpecialtiesHealth Technology XableCath, Inc. manufactures catheters for treatment of vascular diseases. The company was founded by Johannes B. Dahm and Lisa Jordan Dunlea in 2014 and is headquartered in Salt Lake City, UT. | Medical Specialties | Director/Board Member | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Seventh Sense, Inc. | Director/Board Member | ||
The Academy of Food Law & Policy, Inc. | Director/Board Member | ||
Colabs International Corp.
![]() Colabs International Corp. Pharmaceuticals: MajorHealth Technology Colabs International Corp. is a pharmaceutical company that develops formulations and medicines. The company’s targeted epidermal-drug delivery system which is identified as QuantaSphere Technology for cosmeceuticals, fragrances, antibacterial, anti-viral sanitizers, cleaners, and topical pharmacology. It also offers sunscreen, pest repellents, and sanitizers, soap distribution for the firm’s Klenskin products internationally. Its QuantaSphere Technology formulations provide proprietary, epidermal therapeutic effects and also blends consumer needs for a healthy lifestyle with targeted, eco-friendly, multi-tasking products. The company was founded by Laura Cohen and Lisa Leblanc on August 5, 2008 and is headquartered in Huntington Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Miscellaneous Commercial Services | Chairman | |
ImmuneID, Inc.
![]() ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Atelerix Life Sciences, Inc.
![]() Atelerix Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Atelerix Life Sciences, Inc. is a pharmaceutical company that is developing a new drug, ATLX-0199, to address the unmet need of opioid-induced respiratory depression (OIRD) in surgical patients. The company is based in Charlottesville, VA. Atelerix Life Sciences was founded by David G. Kalergis, Benjamin Gaston, James Bates, and Stephen Lewis, with David G. Kalergis serving as the CEO since incorporation. The current drug for OIRD, Naloxone, is problematic and used infrequently because it reverses pain relief. ATLX-0199 safely stimulates opioid-depressed respiratory drive without interfering with opioid-induced analgesia. | Pharmaceuticals: Major | Director/Board Member | |
Implant Therapeutics
![]() Implant Therapeutics Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., Implant Therapeutics is a Canadian biotechnology company that develops therapeutic products in the immunology, mesenchymal stem cell, and pancreatic islet space. The company partners with other companies to develop novel products in other areas of regenerative medicine. Under the guidance of Dr. Mahendra Rao, Implant Therapeutics engineers hypoimmunogenic and safe-harbor technologies in ipsc-msc and islets. These cells are an ideal choice for bone, cartilage, and tendon replacement strategies, combining the advantages of allogeneic and autologous cells, as well as allowing them to be used as ex-vivo gene therapy vehicles. The CEO of the company is Mahendra S. Rao. | Miscellaneous Commercial Services | Chief Executive Officer | |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member | |
P. E. Grebow Consulting, Inc. | Founder |
Statistik
International
Vereinigte Staaten | 45 |
Kanada | 4 |
Indien | 3 |
Frankreich | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 12 |
Commercial Services | 9 |
Finance | 6 |
Government | 4 |
Operativ
Director/Board Member | 76 |
Corporate Officer/Principal | 22 |
Independent Dir/Board Member | 16 |
Founder | 7 |
Undergraduate Degree | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Peter Hutt | 69 |
Mahendra S. Rao | 15 |
Peter E. Grebow | 12 |
Steve J. Borst | 10 |
Thomas Parks | 7 |
Deborah A. Eppstein | 7 |
Hunter Jackson | 6 |
- Börse
- Insiders
- Nicholas Maragakis
- Unternehmensverbindungen